TROP2-XPAT

N/A

Report date: 2026/03/26 20:00:17

Base Information

Drug NameTROP2-XPAT

Drug Alias NameTROP2-XPAT

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibodyBiologics > T cell engagers

Mechanisms of ActionTumor-associated calcium signal transducer 2 inhibitorsT cell surface glycoprotein CD3 modulators

TargetsTumor-associated calcium signal transducer 2T cell surface glycoprotein CD3

Therapy Area/IndicationsSolid tumours

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesAmunix Pharmaceuticals Inc

China Registration ClassN/A

Develop Information

Active CompaniesAmunix Pharmaceuticals Inc

Inactive CompaniesN/A

Active IndicationsSolid tumours

Inactive IndicationsN/A

Other Information

ATC CodeN/A